All posts tagged "CDSCO"
-
392NEWSGambia-Uzbekistan By-product: India Initiates System of Checking Cough Syrups in Govt Labs before Exporting
On May 22, a notification was issued by the Ministry of Commerce and Industry, Directorate General of Foreign Trade, revising the policy...
-
3731HEALTHVaccine-cum-villain: Govt admits the side effects of covid-19 vaccines in RTI reply; Covishield takes most blame
Mumbai:It’s official. The government’s two top watchdogs have admitted to ‘multiple side-effects’ of Covid-19 vaccines that were jabbed in over a billion...
-
464HEALTHWorld’s 1st Intranasal Covid vax from Bharat Biotech gets CDSCO approval
Hyderabad: Leading vaccine maker, Bharat Biotech International Limited (BBIL) on Monday announced that world’s first intranasal vaccine for Covid-19, iNCOVACC (BBV154), has...
-
266NEWS‘Misleading, fallacious’: Govt rubbishes media reports claiming Covaxin approval due to political pressure
The Central Drugs Standard Control Organization’s Subject Expert Committee met on January 1 and 2, 2021 and made recommendations on Bharat Biotech’s...
-
527MUST KNOWDrugs board orders probe after WHO’s alert against India-made cough syrups
The Central Drugs Standard Control Organisation (CDSCO) has launched a probe after the World Health Organisation issued an alert against four India-made...
-
441NEWSCoronavirus News LIVE Updates: India Sees Covid Spike with 2,183 New Infections; Weekly Cases Surge by 35%
Coronavirus News LIVE Updates: India logged 2,183 new coronavirus infections taking the total tally of Covid-19 cases to 4,30,44,280, while the active cases...
-
547MUST KNOWClinical Trials of Bharat Biotech’s Covaxin Begins on Children at AIIMS, Patna
Patna: In a major development, Bharat Biotech has begun clinical trials of its COVID-19 vaccine on children aged 2 to 18 years at...
-
429MUST KNOW
Coronavirus vaccine update: Bharat Biotech’s Covaxin cleared for Phase 3 Human Trials in India; Check key details
Coronavirus Vaccine in India: Experimental Covid-19 vaccine candidate Covaxin has been granted approval for Phase 3 Human Trial in India. Bharat Biotech’s...
-
1.9KMUST KNOWCorona Vaccine Update: COVID-19 Vaccine ‘Might be Much More Effective in Preventing Moderate to Severe Infection,’ Says Drug Authority
Corona Vaccine Update: The Central Drugs Standard Control Organisation (CDSCO) has said that a COVID-19 vaccine candidate should show at least 50 per...
-
1.3KMUST KNOWExplained: What is Covaxin, India’s Covid-19 vaccine candidate; how long before approval?
India’s top drug regulator, the Central Drugs Standard Control Organisation, has allowed Bharat Biotech India (BBIL) to conduct human clinical trials for ‘Covaxin’, making...
